StockOtters
StockOttersSupply Chain Map
Yungjin Pharm. Co., Ltd. logo

Yungjin Pharm. Co., Ltd.

003520.KS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
189
Cost of Revenue
129
Gross Profit
60
Gross Margin
31.9%
Operating Income
7
Operating Margin
3.5%
Net Income
1
Net Margin
0.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
13
EBITDA Margin
6.7%

2023

12/31/2023

Revenue
176
Cost of Revenue
122
Gross Profit
54
Gross Margin
30.7%
Operating Income
2
Operating Margin
1.3%
Net Income
-3
Net Margin
-1.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
6
EBITDA Margin
3.3%

2022

12/31/2022

Revenue
164
Cost of Revenue
115
Gross Profit
49
Gross Margin
29.6%
Operating Income
-6
Operating Margin
-3.4%
Net Income
-16
Net Margin
-10.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-11
EBITDA Margin
-6.5%

2021

12/31/2021

Revenue
147
Cost of Revenue
104
Gross Profit
43
Gross Margin
29.5%
Operating Income
-10
Operating Margin
-7.1%
Net Income
-9
Net Margin
-5.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-5
EBITDA Margin
-3.3%

2020

12/31/2020

Revenue
156
Cost of Revenue
101
Gross Profit
55
Gross Margin
35.2%
Operating Income
1
Operating Margin
0.3%
Net Income
-0
Net Margin
-0.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
6
EBITDA Margin
4.0%